Primary SARS‐CoV‐2 infection in children and adults results in similar Fc‐mediated antibody effector function patterns
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Anne T Gelderloos, Anke J Lakerveld, Rutger M Schepp, Mioara Alina Nicolaie, Josine van Beek, Lisa Beckers, Robert S van Binnendijk, Nynke Y Rots, Puck B van Kasteren |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Enhancing Fc‐mediated effector functions of monoclonal antibodies: The example of HexaBodies
by: Hilma J. van der Horst, et al.
Published: (2024)
by: Hilma J. van der Horst, et al.
Published: (2024)
Fc‐FcγR interactions during infections: From neutralizing antibodies to antibody‐dependent enhancement
by: Julia E. Edgar, et al.
Published: (2024)
by: Julia E. Edgar, et al.
Published: (2024)
Using IMGT unique numbering for IG allotypes and Fc‐engineered variants of effector properties and half‐life of therapeutic antibodies
by: Marie‐Paule Lefranc, et al.
Published: (2024)
by: Marie‐Paule Lefranc, et al.
Published: (2024)
Living in LALA land? Forty years of attenuating Fc effector functions
by: Geoff Hale
Published: (2024)
by: Geoff Hale
Published: (2024)
A Novel Prophylaxis Strategy Using Ecotin as A Promising Adjuvant for Fc‐RBD Fusion Protein Vaccine of SARS ‐ CoV ‐2
by: Yakun Sun, et al.
Published: (2025)
by: Yakun Sun, et al.
Published: (2025)
Functional Fc receptors are crucial in antibody‐mediated protection against cytomegalovirus
by: Anna Bootz, et al.
Published: (2024)
by: Anna Bootz, et al.
Published: (2024)
From Spike to Strike: SARS ‐ CoV ‐2 mRNA Vaccines Sensitise Tumours to PD ‐1/ PD ‐ L1 Blockade
by: Julian Jamie Freen‐van Heeren
Published: (2025)
by: Julian Jamie Freen‐van Heeren
Published: (2025)
SARS‐CoV‐2‐infected human airway epithelial cell cultures uniquely lack interferon and immediate early gene responses caused by other coronaviruses
by: Ying Wang, et al.
Published: (2024)
by: Ying Wang, et al.
Published: (2024)
Chimerism of avian IgY‐scFv and truncated IgG‐Fc: A novel strategy in cross‐species antibody generation and enhancement
by: Shikun Ge, et al.
Published: (2024)
by: Shikun Ge, et al.
Published: (2024)
Similar Spatial Expression of Immune‐Related Proteins in SARS‐CoV‐2 Placentitis and Chronic Histiocytic Intervillositis
by: Michelle Broekhuizen, et al.
Published: (2025)
by: Michelle Broekhuizen, et al.
Published: (2025)
Neutralising antibody responses to emerging SARS ‐ CoV ‐2 omicron sub‐variants are enhanced in persons with hybrid immunity
by: Sharon L Walmsley, et al.
Published: (2026)
by: Sharon L Walmsley, et al.
Published: (2026)
SARS‐CoV‐2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in Adults
by: Lisan H. Kuijper, et al.
Published: (2026)
by: Lisan H. Kuijper, et al.
Published: (2026)
Heterogeneous Activated B Cell Compartments Arising Early and Transiently After SARS‐CoV‐2 Vaccination
by: Laura Fernandez Blanco, et al.
Published: (2026)
by: Laura Fernandez Blanco, et al.
Published: (2026)
The role of peripheral serotonin in SARS ‐ CoV ‐2 infectivity, COVID ‐19 treatment and long COVID
by: Daniel W Thorpe, et al.
Published: (2026)
by: Daniel W Thorpe, et al.
Published: (2026)
Structural Immunology of SARS‐CoV‐2
by: Meng Yuan, et al.
Published: (2024)
by: Meng Yuan, et al.
Published: (2024)
IgE versus IgG and IgA: Differential roles of allergen‐specific antibodies in sensitization, tolerization, and treatment of allergies
by: E. F. Knol, et al.
Published: (2024)
by: E. F. Knol, et al.
Published: (2024)
Rituximab‐to‐vaccine interval on SARS‐CoV‐2 immunogenicity in children: The potential role of prior natural infection
by: Renato Gualtieri, et al.
Published: (2024)
by: Renato Gualtieri, et al.
Published: (2024)
Humoral and cellular immune responses in vaccinated and unvaccinated children following SARS‐CoV‐2 Omicron infection
by: Zheng Quan Toh, et al.
Published: (2024)
by: Zheng Quan Toh, et al.
Published: (2024)
Serum AZD7442 (tixagevimab–cilgavimab) concentrations and in vitroIC50 values predict SARS‐CoV‐2 neutralising antibody titres
by: Lindsay E Clegg, et al.
Published: (2024)
by: Lindsay E Clegg, et al.
Published: (2024)
Humoral epitope dominance and immune imprinting by SARS ‐ CoV ‐1 and SARS ‐ CoV ‐2 vaccines
by: Deborah L Burnett, et al.
Published: (2026)
by: Deborah L Burnett, et al.
Published: (2026)
Testosterone and estradiol reduce inflammation of human macrophages induced by anti‐SARS‐CoV‐2 IgG
by: Sona Allahverdiyeva, et al.
Published: (2024)
by: Sona Allahverdiyeva, et al.
Published: (2024)
Asymptomatic SARS‐CoV‐2 infection: A possible role of platelet HLA class I expression level
by: Rocco Cantisani, et al.
Published: (2024)
by: Rocco Cantisani, et al.
Published: (2024)
Prolonged persistence of tissue‐resident memory cells in the upper airway following SARS ‐ CoV ‐2 infection and vaccination
by: Hyunkyung Cha, et al.
Published: (2026)
by: Hyunkyung Cha, et al.
Published: (2026)
SARS‐CoV‐2 infection negatively impacts on the quality of embryos by delaying early embryonic development
by: Linna Ma, et al.
Published: (2024)
by: Linna Ma, et al.
Published: (2024)
Involvement of SARS‐CoV‐2 accessory proteins in immunopathogenesis
by: Hayato Ito, et al.
Published: (2024)
by: Hayato Ito, et al.
Published: (2024)
SARS‐CoV‐2 infection induces thymic atrophy mediated by IFN‐γ in hACE2 transgenic mice
by: Zaigham Abbas Rizvi, et al.
Published: (2024)
by: Zaigham Abbas Rizvi, et al.
Published: (2024)
Non‐Neutralising Antibodies and T Cell Responses to SARS ‐ CoV ‐2 Detected in Unvaccinated SARS ‐ CoV ‐2‐Naive Spanish Adolescents
by: Hector F. Pelaez‐Prestel, et al.
Published: (2025)
by: Hector F. Pelaez‐Prestel, et al.
Published: (2025)
Polymyalgia Rheumatica Post-SARS-CoV-2 Infection
by: Carolina Duarte-Salazar, et al.
Published: (2024)
by: Carolina Duarte-Salazar, et al.
Published: (2024)
Virological characteristics of the SARS‐CoV‐2 Omicron EG.5.1 variant
by: Shuhei Tsujino, et al.
Published: (2024)
by: Shuhei Tsujino, et al.
Published: (2024)
Protective role of antibodies in enteric virus infections: Lessons from primary and secondary immune deficiencies
by: Quentin Riller, et al.
Published: (2024)
by: Quentin Riller, et al.
Published: (2024)
Effect of Bacille Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2 and COVID‐19 vaccination
by: Nicole L Messina, et al.
Published: (2025)
by: Nicole L Messina, et al.
Published: (2025)
Single‐cell transcriptomic and T cell antigen receptor analysis of human cytomegalovirus ( hCMV )‐specific memory T cells reveals effectors and pre‐effectors of CD8 + ‐ and CD4 + ‐cytotoxic T cells
by: Raunak Kar, et al.
Published: (2024)
by: Raunak Kar, et al.
Published: (2024)
Fc gamma receptors: Their evolution, genomic architecture, genetic variation, and impact on human disease
by: Sarah Frampton, et al.
Published: (2024)
by: Sarah Frampton, et al.
Published: (2024)
Omicron breakthrough infections after triple‐dose inactivated COVID‐19 vaccination: A comprehensive analysis of antibody and T‐cell responses
by: Tiandan Xiang, et al.
Published: (2024)
by: Tiandan Xiang, et al.
Published: (2024)
Increase of post–SARS‐CoV‐2 rashes mimicking penicillin allergy in children with Group A beta‐hemolytic Streptococcus infection: An emerging and challenging issue
by: Francesco Catamerò, et al.
Published: (2026)
by: Francesco Catamerò, et al.
Published: (2026)
Hyperinflammation by Human Macrophages Induced by SARS‐CoV‐2 Anti‐Spike IgG Is Dependent on Glucose and Fatty Acid Metabolism
by: Chiara E. Geyer, et al.
Published: (2025)
by: Chiara E. Geyer, et al.
Published: (2025)
SARS‐CoV‐2‐associated T‐cell infiltration in the central nervous system
by: Malte Mohme, et al.
Published: (2024)
by: Malte Mohme, et al.
Published: (2024)
Deciphering the IgG Idiotype Network Through Proteomic Analysis of Potential Targets in SARS‐CoV‐2‐Induced Immune Responses
by: Nicolle Rakanidis Machado, et al.
Published: (2025)
by: Nicolle Rakanidis Machado, et al.
Published: (2025)
A Structural Voyage Toward the Landscape of Humoral and Cellular Immune Escapes of SARS‐CoV‐2
by: Jun Liu, et al.
Published: (2025)
by: Jun Liu, et al.
Published: (2025)
Molecular and Functional Characterization of Sika Deer ACE2 as a Receptor for SARS‐CoV‐2
by: Anastasiia Kovba, et al.
Published: (2025)
by: Anastasiia Kovba, et al.
Published: (2025)
Similar Items
-
Enhancing Fc‐mediated effector functions of monoclonal antibodies: The example of HexaBodies
by: Hilma J. van der Horst, et al.
Published: (2024) -
Fc‐FcγR interactions during infections: From neutralizing antibodies to antibody‐dependent enhancement
by: Julia E. Edgar, et al.
Published: (2024) -
Using IMGT unique numbering for IG allotypes and Fc‐engineered variants of effector properties and half‐life of therapeutic antibodies
by: Marie‐Paule Lefranc, et al.
Published: (2024) -
Living in LALA land? Forty years of attenuating Fc effector functions
by: Geoff Hale
Published: (2024) -
A Novel Prophylaxis Strategy Using Ecotin as A Promising Adjuvant for Fc‐RBD Fusion Protein Vaccine of SARS ‐ CoV ‐2
by: Yakun Sun, et al.
Published: (2025)